Sonoma Pharmaceuticals Stock Analysis

Sonoma Stock Analysis Notes

The company has price-to-book ratio of 1.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sonoma Pharmaceuticals recorded a loss per share of 2.26. The entity last dividend was issued on the 20th of June 2019. The firm had 1:20 split on the 30th of August 2024. Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia. Sonoma Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To find out more about Sonoma Pharmaceuticals contact Amy Trombly at 800 759 9305 or learn more at https://sonomapharma.com.

Sonoma Pharmaceuticals Investment Alerts

Sonoma Pharmaceuticals Upcoming and Recent Events

Sonoma Largest EPS Surprises

View All Earnings Estimates

Sonoma Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Sonoma Stock Institutional Investors

Note, although Sonoma Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sonoma Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.22 M.

Sonoma Profitablity

The company has Profit Margin (PM) of (0.27) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.29) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.29.

Management Efficiency

Sonoma Pharmaceuticals has return on total asset (ROA) of (0.1972) % which means that it has lost $0.1972 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6483) %, meaning that it created substantial loss on money invested by shareholders. Sonoma Pharmaceuticals' management efficiency ratios could be used to measure how well Sonoma Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of March 25, 2025, Return On Tangible Assets is expected to decline to -0.31. In addition to that, Return On Capital Employed is expected to decline to -0.4. At present, Sonoma Pharmaceuticals' Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 2.9 M, whereas Total Assets are forecasted to decline to about 15.3 M.

Technical Drivers

As of the 25th of March, Sonoma Pharmaceuticals has the Coefficient Of Variation of 1361.57, risk adjusted performance of 0.075, and Semi Deviation of 4.24. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sonoma Pharmaceuticals, as well as the relationship between them.

Sonoma Pharmaceuticals Price Movement Analysis

Sonoma Pharmaceuticals Insider Trading Activities

Sonoma Pharmaceuticals Outstanding Bonds

Sonoma Pharmaceuticals Predictive Daily Indicators

Sonoma Pharmaceuticals Corporate Filings

Sonoma Pharmaceuticals Forecast Models

Sonoma Pharmaceuticals' time-series forecasting models are one of many Sonoma Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sonoma Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sonoma Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sonoma shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sonoma Pharmaceuticals. By using and applying Sonoma Stock analysis, traders can create a robust methodology for identifying Sonoma entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sonoma analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sonoma analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Sonoma Pharmaceuticals stock analysis indicators help investors evaluate how Sonoma Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sonoma Pharmaceuticals shares will generate the highest return on investment. By understating and applying Sonoma Pharmaceuticals stock analysis, traders can identify Sonoma Pharmaceuticals position entry and exit signals to maximize returns.

When running Sonoma Pharmaceuticals' price analysis, check to measure Sonoma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonoma Pharmaceuticals is operating at the current time. Most of Sonoma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Sonoma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonoma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Sonoma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.